These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 59833)

  • 1. [Diagnostic importance of visken -- an adrenergic beta receptor blocking agent].
    Kenedi I
    Kardiologiia; 1975 Sep; 15(9):129-33. PubMed ID: 59833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
    Korkushko OV; Shatilo VB; Butenko AG
    Sov Med; 1989; (12):66-8. PubMed ID: 2483591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of visken and hyperstat in hypertensive crisis].
    Gorbacgenkov AA; Savenkov PM; Klevtsova MN; Ozherel'eva NI; Albegov AS
    Kardiologiia; 1979 Aug; 19(8):95-9. PubMed ID: 491366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken)].
    Friedemann M
    Schweiz Med Wochenschr; 1975 Jul; 105(30):957-61. PubMed ID: 50620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On aspecific primary changes in ventricular repolarization after intravenous injection of dihydroergotamine. Apropos of 60 cases].
    Poggio GL; Ferrari GM
    Minerva Cardioangiol; 1969 Sep; 17(9):609-27. PubMed ID: 5398479
    [No Abstract]   [Full Text] [Related]  

  • 8. [The characteristics of using visken in middle-aged and elderly patients with arterial hypertension].
    Tokar AV; Iena LM; Kozymenko TM; Shyshkina OS
    Lik Sprava; 1993; (10-12):34-8. PubMed ID: 8030304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraction and output capacity of the heart with coronary disease during beta adrenolysis using LB 46 (visken)].
    Limbourg P; Just H
    Z Kreislaufforsch; 1972 Sep; 61(9):789-801. PubMed ID: 4637850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD
    Sov Med; 1990; (3):64-7. PubMed ID: 2195673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of adrenergic beta receptor blockaders on bronchial patency in ischemic heart disease].
    Maksimova LN; Sandomirskiĭ BL
    Kardiologiia; 1978 Apr; 18(4):106-9. PubMed ID: 27664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term blood pressure control with pindolol given once daily.
    Frithz G; Danielson M; Henningsen N; Malmborg RO; Nordström-Ohrberg G; Schröder G
    Eur J Cardiol; 1978; 7(2-3):131-6. PubMed ID: 27369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term ECG recording and cardiac rhythm disorders in patients with different conditions of the coronary arteries (according to the angiographic data)].
    Mazur NA; Matveeva LS; Smirnova TM; Mazaev VP
    Kardiologiia; 1977 Apr; 17(4):11-5. PubMed ID: 69739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
    Golikov AP; Orlov AI; Ivleva VI; Stepura OB
    Kardiologiia; 1980 Oct; 20(10):35-40. PubMed ID: 6108378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of tachycardial disturbances of the cardiac rhythm with a beta-adrenergic blocking agent (Visken)].
    Ley H; Ohlen J; von Richthofen W
    Munch Med Wochenschr; 1970 Nov; 112(48):2183-6. PubMed ID: 4098955
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of beta-adrenergic blockade (Visken) on heart rate orthoclinostatic response and on hypertensive pressor reflex in a mental exertion model (author's transl)].
    Chrástek J; Kavánková M
    Sb Lek; 1976 May; 78(5):133-40. PubMed ID: 935792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.